Screener
Bicara Therapeutics BCAX Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Bicara Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Bicara Therapeutics’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033429
FAQ
- What is Bicara Therapeutics's debt-to-equity?
- Bicara Therapeutics (BCAX) reported debt-to-equity of 0× in Q1 2026.
- How has Bicara Therapeutics's debt-to-equity changed year-over-year?
- Bicara Therapeutics's debt-to-equity increased by 115.4% year-over-year, from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Bicara Therapeutics's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude